Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep;18(9):1226-9.
doi: 10.1038/nn.4085.

Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS

Ana Jovičić  1 , Jerome Mertens  2 , Steven Boeynaems  3   4 , Elke Bogaert  3   4 , Noori Chai  1   5 , Shizuka B Yamada  1   6 , Joseph W Paul 3rd  1 , Shuying Sun  7 , Joseph R Herdy  2 , Gregor Bieri  1   5 , Nicholas J Kramer  1   5 , Fred H Gage  2 , Ludo Van Den Bosch  3   4 , Wim Robberecht  3   4   8 , Aaron D Gitler  1
Affiliations

Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS

Ana Jovičić et al. Nat Neurosci. 2015 Sep.

Abstract

C9orf72 mutations are the most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Dipeptide repeat proteins (DPRs) produced by unconventional translation of the C9orf72 repeat expansions cause neurodegeneration in cell culture and in animal models. We performed two unbiased screens in Saccharomyces cerevisiae and identified potent modifiers of DPR toxicity, including karyopherins and effectors of Ran-mediated nucleocytoplasmic transport, providing insight into potential disease mechanisms and therapeutic targets.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Yeast screens identify potent modifiers of C9orf72 DPR toxicity. a) Arginine-rich C9orf72 DPRs are toxic in yeast. Spotting assay demonstrates (GR)50 and (PR)50 constructs are toxic when expressed in yeast. Galactose was used to induce expression of each DPR construct and glucose was used to repress expression. Five-fold serial dilutions of yeast cells were spotted on glucose- or galactose-containing plates. b) (GR)50 is less toxic than (PR)50 and increasing the DPR length to 100 increased GR toxicity. c) Schematic of plasmid overexpression screen to identify genes that suppress or enhance (PR)50 toxicity when overexpressed. d) Examples of overexpression suppressors of (PR)50 toxicity include members of the karyopherin family of nuclear transport proteins. e) Schematic of yeast deletion screen to identify genes that suppress (PR)50 toxicity when deleted. f) Examples of deletion suppressors of (PR)50 toxicity, including gtr1Δ, a negative regulator of the Ran-GTPase cycle and nsr1Δ, a deletion of the yeast homolog of the human nucleolar protein nucleolin. g) A model depicting where the modifier genes from deletion and overexpression screens function. Genes colored blue suppressed toxicity when deleted. Genes colored red enhanced toxicity when overexpressed. Genes colored green suppressed toxicity when overexpressed. h) Upregulation of KPNA3 protects against (PR)50 toxicity in rodent neurons. Upregulation of KPNA3 more than doubled the survival of the neurons expressing (PR)50 compared to co-infection with GFP. Graph represents mean ± SEM, n = 6. ** represents p-value <0.01, by unpaired t-test. i) C9orf72-ALS patient-derived neurons show decreased nuclear localization of RCC1 (human homolog of yeast SRM1) compared to healthy control-derived neurons. j) Quantitation of nuclear vs. cytoplasmic fluorescence intensity for RCC1. Human induced neurons from 3 healthy control subjects and 2 C9orf72-ALS patients were compared. Graph represents mean ± SEM, n = 13 (healthy controls), n = 8 (C9orf72-ALS) ** represents P <0.01, by unpaired t-test.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. DeJesus-Hernandez M, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245–256. - PMC - PubMed
    1. Renton AE, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257–268. - PMC - PubMed
    1. Ash PE, et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron. 2013;77:639–646. - PMC - PubMed
    1. Mori K, et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013;339:1335–1338. - PubMed
    1. Zu T, et al. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl. Acad. Sci. U.S.A. 2013;110:E4968–E4977. - PMC - PubMed

Online References

    1. Hu Y, et al. Approaching a complete repository of sequence-verified protein-encoding clones for Saccharomyces cerevisiae. Genome Res. 2007;17:536–543. - PMC - PubMed
    1. Tong AH, et al. Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science. 2001;294:2364–2368. - PubMed
    1. Collins SR, Schuldiner M, Krogan NJ, Weissman JS. A strategy for extracting and analyzing large-scale quantitative epistatic interaction data. Genome Biol. 2006;7:R63. - PMC - PubMed
    1. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009;4:44–57. - PubMed
    1. Lagier-Tourenne C, et al. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc. Natl. Acad. Sci. U.S.A. 2013;110:E4530–E4539. - PMC - PubMed

Publication types